Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-16

Clinical Trial Update: Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness and safety of treatments for spondyloarthritis related to inflammatory bowel disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Spondyloarthritis, Crohn's Disease | Phase 4 | Status: WITHDRAWN